Skip to main content
Caplight Logo









Helyxon

Helyxon

Private
ChennaiHealthcare & Life Scienceshttps://helyxon.com

Last Round

Seed

Apr 9, 2017

Total Funding Raised

$540,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Helyxon operates in Healthcare & Life Sciences and is based in Chennai. Its latest recorded funding round was a Seed round in April 2017.

Helyxon is a healthtech company that develops a technology platform for remote patient monitoring solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Health IoT, Patient Engagement, IoT Hardware

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Helyxon Comparables

Compare Helyxon with similar companies based on industry and business-model similarity.

Helyxon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MedTel Healthcare
87%
LifeSigns
83%
Dozee
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Helyxon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Suthanraj Natarajan

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 37, 2.2x the trailing average.

  • Jan 23, 2026

    Monthly visitors increased 63% MoM, reaching 2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Helyxon Filings

Explore SEC and related filing metadata, where available.

Helyxon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Helyxon's valuation, stock price, and market status.

Is Helyxon a public or private company?

Helyxon is a private company.

What is the current stock price of Helyxon?

Helyxon is a private company, so its shares have no public market price. Caplight tracks Helyxon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Helyxon worth (valuation)?

Valuation information for Helyxon is not publicly available.

Can I buy Helyxon stock?

Helyxon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Helyxon's last funding round?

Helyxon's most recent funding round was Seed on April 9, 2017.

Who are the main investors in Helyxon?

Investor information for Helyxon is not publicly disclosed.

Will Helyxon IPO soon?

No public IPO plans have been announced for Helyxon.

How can I track Helyxon secondary market activity?

Caplight tracks bids, offers, and trades in Helyxon's shares on secondary markets.

Firmographic Details

HeadquartersChennai
Employee Range24
Year Founded2014
Last FundingApr 9, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?